Fraunhofer USA to support DTRA's Chemical and Biological Directorate

Biotech firm Fraunhofer USA Center for Molecular Biotechnology, based in Newark, Delaware, recently received a $1.51 million federal contract to support its ongoing research for the U.S. Department of Defense.

The Defense Advanced Threat Reduction Agency in Ft. Belvoir, Virginia, awarded the contract to Fraunhofer USA CMB, a subsidiary of Germany-based Fraunhofer Gesellschaft, for its lead in innovative research projects that support DTRA’s Chemical and Biological Directorate, according to

In early July, Fraunhofer USA CMB signed a six year agreement with the University of Delaware to help facilitate the transfer of university-based research into marketable biotechnology products.

“By translating basic discoveries into clinical and commercial applications, the combined strengths of the two institutions could lead to significant economic benefit for Delaware and the region,” Delaware Governor Jack Markell said, reports. “The discoveries that have been and will be made at these facilities can have an impact worldwide. Our state has a well-earned reputation as a center for excellence and innovation, which this partnership furthers.”

The agreement is expected to generate $32 million in investment over the next six years shared among the state of Delaware, UD and Fraunhofer, according to

Fraunhofer will match at least $18 million coming from the state and UD with its own investments in research, and by expanding laboratory facilities and staff hiring.

Organizations in this Story

U.S. Department of Defense

Want to get notified whenever we write about U.S. Department of Defense ?
Next time we write about U.S. Department of Defense, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.